Global and China Biologics and Biosimilars Market Research Report Forecast 2017-2021

March 2017 | 103 pages | ID: GEA942420A6EN
S&P Consulting

Abstracts

The Global and China Biologics and Biosimilars Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Biologics and Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Biologics and Biosimilars market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global and China Biologics and Biosimilars Market: Regional Segment Analysis

• Global
• China

The Major players reported in the market include:
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
company 9
Global and China Biologics and Biosimilars Market: Product Segment Analysis
Biologics
Biosimilars

• Type III

Global and China Biologics and Biosimilars Market: Application Segment Analysis
Tumor
Diabetes
Cardiovascular

REASONS FOR BUYING THIS REPORT

This report provides pin-point analysis for changing competitive dynamics

• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 BIOLOGICS AND BIOSIMILARS MARKET OVERVIEW

1.1 Biologics and Biosimilars Definition
1.2 Biologics and Biosimilars Classification and Application
1.3 Biologics and Biosimilars Industry Chain
1.4 Biologics and Biosimilars Industry Overview

CHAPTER 2 GLOBAL AND CHINA ECONOMIC IMPACT ON BIOLOGICS AND BIOSIMILARS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
2.2 China Macroeconomic Environment Analysis

CHAPTER 3 GLOBAL BIOLOGICS AND BIOSIMILARS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

3.1 Global Biologics and Biosimilars Market Competition by Manufacturers
  3.1.1 Global Biologics and Biosimilars Production and Market Share of Key Manufacturers (2012-2017)
  3.1.2 Global Biologics and Biosimilars Revenue and Share by Manufacturers (2012-2017)
3.2 Global Biologics and Biosimilars Production and Revenue by Type
  3.3.1 Global Biologics and Biosimilars Production and Market Share by Type (2012-2017)
  3.3.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
3.3 Global Biologics and Biosimilars Production and Revenue by Application

CHAPTER 4 CHINA BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS

4.1 China Biologics and Biosimilars Production and Revenue (2012-2014)
  4.1.1 China Biologics and Biosimilars Production and Growth Rate (2012-2014)
  4.1.2 China Biologics and Biosimilars Revenue and Growth Rate (2012-2014)
  4.1.3 China Biologics and Biosimilars Sales Price Trend (2012-2014)
4.2 China Biologics and Biosimilars Production and Market Share by Manufacturers
4.3 China Biologics and Biosimilars Production and Market Share by Type
4.4 China Biologics and Biosimilars Production and Market Share by Application

CHAPTER 5 GLOBAL BIOLOGICS AND BIOSIMILARS MANUFACTURERS ANALYSIS

5.1 Pfizer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Product Type, Application and Specification
  5.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.1.4 Business Overview
5.2 Roche
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 Product Type, Application and Specification
  5.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.2.4 Business Overview
5.3 Amgen
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 Product Type, Application and Specification
  5.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.3.4 Business Overview
5.4 AbbVie
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 Product Type, Application and Specification
  5.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.4.4 Business Overview
5.5 Sanofi
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 Product Type, Application and Specification
  5.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.5.4 Business Overview
5.6 Johnson & Johnson
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 Product Type, Application and Specification
  5.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.6.4 Business Overview
5.7 Novo Nordisk
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 Product Type, Application and Specification
  5.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.7.4 Business Overview
5.8 Novartis
  5.8.1 Company Basic Information, Manufacturing Base and Competitors
  5.8.2 Product Type, Application and Specification
  5.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.8.4 Business Overview
5.9 company
  5.9.1 Company Basic Information, Manufacturing Base and Competitors
  5.9.2 Product Type, Application and Specification
  5.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.9.4 Business Overview
…

CHAPTER 6 BIOLOGICS AND BIOSIMILARS MANUFACTURING COST ANALYSIS

6.1 Biologics and Biosimilars Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biologics and Biosimilars

CHAPTER 7 MARKET EFFECT FACTORS ANALYSIS

7.1 Technology Progress/Risk
  7.1.1 Substitutes Threat
  7.1.2 Technology Progress in Related Industry
7.2 Consumer Needs/Customer Preference Change
7.3 Economic/Political Environmental Change

CHAPTER 8 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET FORECAST (2017-2021)

8.1 Global Biologics and Biosimilars Production, Revenue Forecast (2017-2021)
8.2 Global Biologics and Biosimilars Production Forecast by Type (2017-2021)
8.3 Global Biologics and Biosimilars Consumption Forecast by Application (2017-2021)
8.4 China Biologics and Biosimilars Production, Consumption Forecast by Regions (2017-2021)
8.5 Biologics and Biosimilars Price Forecast (2017-2021)

CHAPTER 9 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biologics and Biosimilars
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2015
Table Biologics and Biosimilars Consumption Market Share by Application in 2015
Table Global Biologics and Biosimilars Capacity of Key Manufacturers (2015 and 2016)
Table Global Biologics and Biosimilars Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Biologics and Biosimilars Capacity of Key Manufacturers in 2015
Figure Global Biologics and Biosimilars Capacity of Key Manufacturers in 2016
Table Global Biologics and Biosimilars Production of Key Manufacturers (2015 and 2016)
Table Global Biologics and Biosimilars Production Share by Manufacturers (2015 and 2016)
Figure 2015 Biologics and Biosimilars Production Share by Manufacturers
Figure 2016 Biologics and Biosimilars Production Share by Manufacturers
Table Global Biologics and Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table 2016 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table Global Market Biologics and Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Biologics and Biosimilars Average Price of Key Manufacturers in 2015
Table Manufacturers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Biologics and Biosimilars Product Type
Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
Table Global Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table China Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Biologics and Biosimilars Production by Type (2012-2017)
Table Global Biologics and Biosimilars Production Share by Type (2012-2017)
Figure Production Market Share of Biologics and Biosimilars by Type (2012-2017)
Figure 2015 Production Market Share of Biologics and Biosimilars by Type
Table Global Biologics and Biosimilars Revenue by Type (2012-2017)
Table Global Biologics and Biosimilars Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Biologics and Biosimilars by Type (2012-2017)
Figure 2015 Revenue Market Share of Biologics and Biosimilars by Type
Table Global Biologics and Biosimilars Price by Type (2012-2017)
Figure Global Biologics and Biosimilars Production Growth by Type (2012-2017)
Table Global Biologics and Biosimilars Consumption by Application (2012-2017)
Table Global Biologics and Biosimilars Consumption Market Share by Application (2012-2017)
Figure Global Biologics and Biosimilars Consumption Market Share by Application in 2015
Table Global Biologics and Biosimilars Consumption Growth Rate by Application (2012-2017)
Figure Global Biologics and Biosimilars Consumption Growth Rate by Application (2012-2017)
Figure China Biologics and Biosimilars Production and Growth Rate (2012-2017)
Figure China Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure China Biologics and Biosimilars Production Price Trend (2012-2017)
Table China Biologics and Biosimilars Production by Manufacturers (2012-2017)
Table China Biologics and Biosimilars Market Share by Manufacturers (2012-2017)
Table China Biologics and Biosimilars Production by Type (2012-2017)
Table China Biologics and Biosimilars Market Share by Type (2012-2017)
Table China Biologics and Biosimilars Production by Application (2012-2017)
Table China Biologics and Biosimilars Market Share by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Biologics and Biosimilars Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Roche Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Roche Biologics and Biosimilars Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Biologics and Biosimilars Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AbbVie Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Biologics and Biosimilars Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Biologics and Biosimilars Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Biologics and Biosimilars Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novo Nordisk Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Novo Nordisk Biologics and Biosimilars Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Biologics and Biosimilars Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Biologics and Biosimilars Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure Global Biologics and Biosimilars Production and Growth Rate Forecast (2017-2021)
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Table Global Biologics and Biosimilars Production Forecast by Type (2017-2021)
Table Global Biologics and Biosimilars Consumption Forecast by Application (2017-2021)
Table China Biologics and Biosimilars Production and Consumption Forecast by Regions (2017-2021)